THROMBOTIC MICROANGIOPATHIES
Clinical trials for THROMBOTIC MICROANGIOPATHIES explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHIES trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Abandoned study: could a drug fix Chemo-Related kidney injury?
Disease control TerminatedThis study planned to test the drug eculizumab in cancer patients who developed kidney damage from the chemotherapy drug gemcitabine. The goal was to see if eculizumab could help the kidneys recover. However, the trial was withdrawn before any patients were enrolled, so no data w…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Promising ITP drug trial pulled before it even started
Disease control TerminatedThis study was designed to test the safety and tolerability of a new drug called HMPL-523 (sovleplenib) in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The trial was withdrawn before enrolling any pa…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jun 26, 2026 18:23 UTC